Last updated on September 2020

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

Brief description of study

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported DNA-repair gene defects to assess biomarker eligibility for niraparib interventional studies.

Clinical Study Identifier: NCT03871816

Find a site near you

Start Over

Macquarie University Hospital

North Ryde, Australia
  Connect »

Sydney Adventist Hospital

Wahroonga, Australia
  Connect »

Chris O'Brien Lifehouse

Camperdown, Australia
  Connect »

St Vincent's hospital

Darlinghurst, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.